Annals of Military and Health Sciences Research

Published by: Kowsar

Association of Two Single-Nucleotide Polymorphisms (rs1805087 and rs1801131) with Coronary Artery Disease in Golestan Population

Fahimeh Baghbani-Arani 1 , Mohsen Kavian Telori 2 , Jahanbakhsh Asadi 3 , Esmail Samadian 4 and Atefeh Shirkavand 5 , *
Authors Information
1 Department of Genetics and Biotechnology, School of Biological Science, Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran
2 Department of Biology, Faculty of Sciences, Gilan University, Gilan, Iran
3 Department of Clinical Biochemistry, School of Medicine, Golestan University of Medical Sciences, Gorgon, Iran
4 Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
5 National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
Article information
  • Annals of Military and Health Sciences Research: March 2017, 15 (1); e11473
  • Published Online: March 31, 2017
  • Article Type: Research Article
  • Received: January 2, 2017
  • Accepted: February 20, 2017
  • DOI: 10.5812/amh.11473

To Cite: Baghbani-Arani F, Kavian Telori M, Asadi J, Samadian E, Shirkavand A. Association of Two Single-Nucleotide Polymorphisms (rs1805087 and rs1801131) with Coronary Artery Disease in Golestan Population, Ann Mil Health Sci Res. 2017 ; 15(1):e11473. doi: 10.5812/amh.11473.

Copyright © 2017, Annals of Military and Health Sciences Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001; 285(19): 2481-5
  • 2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104(22): 2746-53[PubMed]
  • 3. Baudhuin LM. Genetics of coronary artery disease: focus on genome-wide association studies. Am J Transl Res. 2009; 1(3): 221-34[PubMed]
  • 4. Masud R, Qureshi IZ. Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease. Mol Cell Biochem. 2011; 355(1-2): 289-97[DOI][PubMed]
  • 5. Szczeklik A, Sanak M, Jankowski M, Dropinski, J. , Czachor, R. , Musial, J. , et al. Mutation A1298C of methylenetetrahydrofolatereductase: Risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet. 2001; 101(1): 36-9
  • 6. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997; 277(22): 1775-81[PubMed]
  • 7. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995; 274(13): 1049-57[PubMed]
  • 8. Lima LM, Carvalho M, Fernandes AP, Sabino Ade P, Loures-Vale AA, da Fonseca Neto CP, et al. Homocysteine and methylenetetrahydrofolate reductase in subjects undergoing coronary angiography. Arq Bras Cardiol. 2007; 88(2): 167-72[PubMed]
  • 9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10(1): 111-3[DOI][PubMed]
  • 10. Faeb D, Chiolero A, Paccaud F. Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about it? Swiss Med Wkly. 2006; 136(47-48): 745-56
  • 11. Guilland JC, Favier A, Potier DCG, Galan P, Hercberg S. Hyperhomocysteinaemia: An independent risk factor or a simple marker of vascular disease? Pathol Biol. 2003; 51(2): 101-10
  • 12. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998; 98(23): 2520-6[PubMed]
  • 13. Bathum L, Petersen I, Christiansen L, Konieczna A, Sorensen TI, Kyvik KO. Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. Clin Chem. 2007; 53(5): 971-9[DOI][PubMed]
  • 14. Laraqui A, Allami A, Carrie A, Raisonnier A, Coiffard AS, Benkouka F, et al. Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease. Eur J Intern Med. 2007; 18(6): 474-83[DOI][PubMed]
  • 15. Vinukonda G, Shaik Mohammad N, Md Nurul Jain J, Prasad Chintakindi K, Rama Devi Akella R. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians. Clin Chim Acta. 2009; 405(1-2): 127-31[DOI][PubMed]
  • 16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. J Nucleic Acids Res. 1988; 16(3): 12-5
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments